Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» NovaBay: Topline Data From 2 Phase IIb Trials Presents Asymmetric Investment Opportunity
NovaBay: Topline Data From 2 Phase IIb Trials Presents Asymmetric Investment Opportunity
NovaBay: Topline Data From 2 Phase IIb Trials Presents Asymmetric Investment Opportunity
Submitted by
admin
on March 19, 2013 - 10:54am
Source:
Seeking Alpha
News Tags:
NovaBay Pharmaceuticals
auriclosene
Galderma
Headline:
NovaBay: Topline Data From 2 Phase IIb Trials Presents Asymmetric Investment Opportunity
Do Not Allow Advertisers to Use My Personal information
